Abstract
To elucidate a possible role of cytoplasmic ATP in the regulation of catecholamine biosynthesis, cultured bovine adrenal chromaffin cells were pretreated with metabolic inhibitors in the glucose-free medium, and the cytoplasmic concentration of ATP was determined by measuring the amount of ATP released by permeabilization of the plasma membranes with digitonin. Catecholamine biosynthetic activity in these metabolic inhibitor-treated cells was determined by measuring the formation of [(14)C]catecholamines from l-[(14)C]tyrosine. The cytoplasmic concentration of ATP was reduced by pretreatment of the cells with 2,4-dinitrophenol (DNP), oligomycin, carbonyl cyanide m-chlorophenylhydrazone (CCCP) and antimycin. These metabolic inhibitors reduced [(14)C]catecholamine formation without any significant alteration in [(14)C]tyrosine uptake into the cells. In addition, the formation of [(14)C]catecholamines stimulated by high K(+) or cyclic AMP was also reduced by these inhibitors. In contrast, both 2-deoxyglucose (2-DG) and NaN(3) failed to cause any substantial effect on the rate of [(14)C]catecholamine formation as well as the ATP concentration in the cell cytoplasm. While, none of these inhibitors caused a direct inhibitory action on tyrosine hydroxylase prepared from bovine adrenal medulla. The results presented here suggest the possibility that ATP in the cell cytoplasm plays an important role as a factor regulating the catecholamine biosynthetic activity in the adrenal chromaffin cell.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.